Riskpilot← Back to searchSign inGet full accessDenator AB
ABActiveOrg 5566647748Norra Ågatan 32Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20040 employees
Revenue 2024
SEK 0
EBITDA margin
—
+226% vs 2023
Equity ratio
25.3%
Financial strength
Net profit 2024
SEK -26K
+92% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 91K | +226% |
| Net profit | SEK -26K | +92% |
| Total assets | SEK 1,4M | -19% |
| Equity | SEK 345K | -7% |
| Employees | 0 | — |
Legal name
Denator AB
Org number
5566647748
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 augusti 2004
Share capital
SEK 669 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten Då minst halva antalet styrelsesuppleanter ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Föremålet för bolagets verksamhet ska vara att direkt eller indirekt bedriva forskning, utveckling, produktion, marknadsföring, licensiering och försäljning av medicinska, biokemiska och biotekniska produkter inom området kvalitetssäkring av biologisk provmateria samt idka därmed förenlig verksamhet.
Address
Norra Ågatan 32
Phone
+4631412891
Email
goran.sorensson@denator.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 498 | 607 | 441 | 838 | 39 | 27 | 20 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −15 809 | −11 458 | −1 190 | −185 | −411 | 32 | −538 | −535 | −72 | 91 |
| Depreciation & amort. | −81 | −57 | −39 | −33 | −33 | −33 | −22 | −779 | −149 | −142 |
| EBIT | −15 890 | −11 515 | −1 229 | −218 | −444 | −1 | −560 | −1 314 | −221 | −51 |
| Net financials | −128 | −35 | −22 | −14 | −36 | −45 | −54 | −108 | −109 | 25 |
| Profit before tax | −16 019 | −11 550 | −1 251 | −232 | −480 | −46 | −615 | −1 422 | −330 | −26 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −16 019 | −11 550 | −1 251 | −232 | −480 | −46 | −615 | −1 422 | −330 | −26 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16 300 | 5 620 | 4 949 | 3 472 | 3 386 | 3 090 | 3 178 | 2 349 | 1 694 | 1 365 |
| Equity | 13 976 | 2 425 | 1 175 | 943 | 463 | 418 | −197 | −1 619 | 371 | 345 |
| Long-term debt | 0 | 0 | 1 010 | 1 870 | 2 170 | 2 170 | 2 770 | 3 270 | 694 | 694 |
| Short-term debt | 2 261 | 3 195 | 2 764 | 659 | 753 | 502 | 605 | 699 | 630 | 326 |
| Total debt | 2 261 | 3 195 | 3 774 | 2 529 | 2 923 | 2 672 | 3 375 | 3 969 | 1 324 | 1 020 |
EBITDA margin
9100000.0%
This company
15.8%
Market median
+57594837% vs market
20152024
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20152024
Return on equity
-7.5%
This company
18.4%
Market median
-141% vs market
20152024
Net profit margin
-2600000.0%
This company
8.1%
Market median
-32098865% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
2.96×
This company
0.62×
Market median
-377% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KW Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Denator AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl William Ekenfall | Chief Auditor | 0 companies |
| Ulf Gunnar Gunnarsson Järnberg | Deputy Board Member | 0 companies |
| Dan Christer Pitulia | Deputy Board Member | 0 companies |
| Dan Christer Pitulia | Deputy Board Member | 0 companies |
| Hans Göran Sörensson | Board of Directors | 0 companies |